Publication Date:
2021
Short description:
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis / Baroncini, Damiano; Simone, Marta; Iaffaldano, Pietro; Brescia Morra, Vincenzo; Lanzillo, Roberta; Filippi, Massimo; Romeo, Marzia; Patti, Francesco; Chisari, Clara Grazia; Cocco, Eleonora; Fenu, Giuseppe; Salemi, Giuseppe; Ragonese, Paolo; Inglese, Matilde; Cellerino, Maria; Margari, Lucia; Comi, Giancarlo; Zaffaroni, Mauro; Ghezzi, Angelo. - In: JAMA NEUROLOGY. - ISSN 2168-6149. - 78:6(2021), pp. 726-735. [10.1001/jamaneurol.2021.1008]
abstract:
Availability of new disease-modifying therapies (DMTs) and changes of therapeutic paradigms have led to a general improvement of multiple sclerosis (MS) prognosis in adults. It is still unclear whether this improvement also involves patients with pediatric-onset MS (POMS), whose early management is more challenging.
Iris type:
1.1 Articolo in rivista
List of contributors:
Baroncini, Damiano; Simone, Marta; Iaffaldano, Pietro; Brescia Morra, Vincenzo; Lanzillo, Roberta; Filippi, Massimo; Romeo, Marzia; Patti, Francesco; Chisari, Clara Grazia; Cocco, Eleonora; Fenu, Giuseppe; Salemi, Giuseppe; Ragonese, Paolo; Inglese, Matilde; Cellerino, Maria; Margari, Lucia; Comi, Giancarlo; Zaffaroni, Mauro; Ghezzi, Angelo
Published in: